[go: up one dir, main page]

ES2010181B3 - Procedimiento para la obtencion de un medicamento. - Google Patents

Procedimiento para la obtencion de un medicamento.

Info

Publication number
ES2010181B3
ES2010181B3 ES86113453T ES86113453T ES2010181B3 ES 2010181 B3 ES2010181 B3 ES 2010181B3 ES 86113453 T ES86113453 T ES 86113453T ES 86113453 T ES86113453 T ES 86113453T ES 2010181 B3 ES2010181 B3 ES 2010181B3
Authority
ES
Spain
Prior art keywords
medication
procedure
obtaining
anipamil
gallopamil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES86113453T
Other languages
English (en)
Inventor
Hans Dieter Lehmann
Rolf Kretzschmar
Klaus-Juergen Hahn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Application granted granted Critical
Publication of ES2010181B3 publication Critical patent/ES2010181B3/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBE UNA ASOCIACION DE VERAPAMIL, GALLOPAMIL Y ANIPAMIL, ASI COMO ACIDO ACETILSALICILICO, EN UNA PROPORCION EN PESO DE 10:1 A 1:20, QUE ESTA INDICADA PARA EL TRATAMIENTO DE LOS TRASTORNOS VASCULARES.
ES86113453T 1985-10-09 1986-10-01 Procedimiento para la obtencion de un medicamento. Expired ES2010181B3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853535950 DE3535950A1 (de) 1985-10-09 1985-10-09 Kombinationspraeparat

Publications (1)

Publication Number Publication Date
ES2010181B3 true ES2010181B3 (es) 1989-11-01

Family

ID=6283102

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86113453T Expired ES2010181B3 (es) 1985-10-09 1986-10-01 Procedimiento para la obtencion de un medicamento.

Country Status (6)

Country Link
US (1) US4798811A (es)
EP (1) EP0219728B1 (es)
JP (1) JPS6293230A (es)
AT (1) ATE45674T1 (es)
DE (2) DE3535950A1 (es)
ES (1) ES2010181B3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039709A (en) * 1989-11-30 1991-08-13 Basf Aktiengesellschaft Anipamil for the treatment of chronic renal failure
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
DE69321596T2 (de) * 1992-07-30 1999-04-22 Cal International Ltd., Dublin Ester und kombinationen von einem organischen nitrat und einem salicyclat
US6083532A (en) 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3144150A1 (de) * 1981-04-10 1982-12-09 Basf Ag, 6700 Ludwigshafen (omega)-cyan-1,(omega)-diphenyl-azaalkan-derivate, ihre herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
US4798811A (en) 1989-01-17
DE3535950A1 (de) 1987-04-09
EP0219728B1 (de) 1989-08-23
EP0219728A1 (de) 1987-04-29
ATE45674T1 (de) 1989-09-15
JPS6293230A (ja) 1987-04-28
DE3665126D1 (en) 1989-09-28

Similar Documents

Publication Publication Date Title
ES511433A0 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
AR241014A1 (es) "procedimiento para la preparacion de feniletanolami-notetralinas de actividad lipolitica"
SE8504720L (sv) Ny lekemedelsberedning
ES520218A0 (es) Un procedimiento para la preparacion de nuevos 2,3-diaril-5-halotiofenos.
EP0285856A3 (en) Use of dihydroergotamine and its salts in the local treatment of trophic disorders
IT1237519B (it) Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina
ES2010181B3 (es) Procedimiento para la obtencion de un medicamento.
ES545155A0 (es) Procedimiento para la obtencion de (pirrol-1-il)-fenil-dihi-dropiridazinona
ES515713A0 (es) "proceso para preparar insulina humana o los esteres b-30 de la misma".
ES522737A0 (es) "procedimiento para la preparacion de un agente para suavizar generos textiles"
ES551485A0 (es) Procedimiento para la preparacion de derivados de all-cis-1,3,5-triamino-2,4,6-trihidrociclohexano
ES557234A0 (es) Un procedimiento para preparar oxadiazolil 1-4-dihidropiridinas.
EP0147707A3 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
IT7824578A0 (it) Composizione farmaceutica per la terapia di stati di frigidita' ed impotenza.
IT8323601A0 (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete.
FI834429A7 (fi) 3',5'-diarabinosidien valmistus ja terapeuttinen soveltaminen.
ES527155A0 (es) Procedimiento para la preparacion de n-pteridinil-ureas(como divisional de la patente numero 521.331)
ES2020562B3 (es) Metodo para regular la reproduccion animal.
MX5413A (es) Procedimiento para la preparacion de n-benzoil-n'-fenilureas.
ES516061A0 (es) "procedimiento para la preparacion simultanea de acido nitrico altamente concentrado y acido nitrico diluido".
DK452788A (da) Smertestillende praeparat
DE3671371D1 (de) Kombinationspraeparat.
ES524353A0 (es) Procedimiento para la preparacion de n-metil-n-bis-(3,4-dimetoxi-fenil-etil)-amina
ES530605A0 (es) Procedimiento para fabricar compuestos piperidinonicos eficaces en el tratamiento de cardiopatias
ES542441A0 (es) "procedimiento para la obtencion del acido 1-ciclopropil-6- fluor--1,4-dihidro-4-oxo-7-(1-piperazinil)-3-quinolincarbo- xilico".